Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ChIP-seq following CRISPRi perturbations to MYC enhancers in K562 cells

ABSTRACT: ChIP-seq following CRISPRi perturbations to MYC enhancers in K562 cells

PROVIDER: PRJNA934120 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23435100_1.fastq.gz	Fastqsanger.gz
	SRR23435100_2.fastq.gz	Fastqsanger.gz
	SRR23435200_1.fastq.gz	Fastqsanger.gz
	SRR23435200_2.fastq.gz	Fastqsanger.gz
	SRR23435101_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 432

Similar Datasets

ChIP-seq following CRISPRi perturbations to MYC enhancers in K562 cells

Project description:We previous identified enhancers that regulate MYC expression in K562 cells (Fulco et al. Science 2016). Here, we perturbed MYC enhancers with individual CRISPRi gRNAs and performed ChIP-seq to study the effects on chromatin state.

2023-11-14 | GSE225157 | GEO

Effects of CYTOR Knockdown via CRISPRi on K562 cells

Project description:Effects of CYTOR Knockdown via CRISPRi on K562 cells

| PRJNA1201158 | ENA

Single-cell CRISPRi screens of breast cancer associated enhancers

Project description:This series contains the single-cell CRISPRi screens of MDA-MB-361 cells and MDA-MB-231 cells targeting 3512 enhancers associated breast cancer GWAS variants and somatic mutations.

2024-11-13 | GSE224986 | GEO

Single-cell CRISPRi screens of breast cancer associated enhancers

Project description:Single-cell CRISPRi screens of breast cancer associated enhancers

| PRJNA933230 | ENA

Jurkat CRISPRi ATAC-seq [Series 3]

Project description:We develop a system for bidirectional epigenetic editing (CRISPRai), in which orthogonal activating (CRISPRa) and repressive (CRISPRi) perturbations are applied simultaneously to multiple loci the same cell. We perform ATAC-seq on CRISPRi perturbed Jurkat T cells to investigate chromatin accessibility changes upon perturbation of individual regulatory elements.

2024-03-16 | GSE261695 | GEO

Effects of CYTOR Knockdown via CRISPRi on K562 cells

Project description:The long noncoding RNA CYTOR has been linked to poor prognosis of cancer, this includes chemo- and radioresistance. Knowing the mechanisms of CYTOR can benefit current cancer therapeuitics. To examine the mechanisms of CYTOR on K562, we performed CRISPRi to knock it down. RNA sequencing were then performed on these knocked down and wild type cells. This is followed by differential gene expression analysis to determine genes and lncRNAs that are differentially regulated when CYTOR is silenced.

2024-12-22 | GSE285084 | GEO

Genetic enhancers of partial PLK1 inhibition reveal hypersensitivity to kinetochore perturbations

Project description:Genetic enhancers of partial PLK1 inhibition reveal hypersensitivity to kinetochore perturbations

| PRJNA948403 | ENA

Bulk ATAC-seq of RPTEC with HNF1B CRISPRi

Project description:We performed bulk ATAC-seq of primary PRTEC after CRISPRi targeting HNF1B promoter and enhancers.

2023-04-24 | GSE227061 | GEO

Genome-wide CRISPRi screen for myriocin sensitivity

Project description:To delineate cellular pathways underlying cell growth in the absence of sphingolipid syntehsis, we performed a genome-wide CRISPRi screen to identify genetic modifiers of myriocin sensitivity in human K562 cells.

2020-07-09 | GSE154045 | GEO

Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations (Nanopore)

Project description:Multiplexed genetic perturbations are critical for testing functional interactions among coding or non-coding genetic elements. Compared to double-stranded DNA cutting, repressive chromatin formation using CRISPR interference (CRISPRi) avoids genotoxicity and is more effective for perturbing non-coding regulatory elements in pooled assays. However, current CRISPRi pooled screening approaches are limited to targeting 1-3 genomic sites per cell. We engineer an Acidaminococcus Cas12a (AsCas12a) variant, multiplexed transcriptional interference AsCas12a (multiAsCas12a), that incorporates R1226A, a mutation that stabilizes the ribonucleoprotein:DNA complex via DNA nicking. The multiAsCas12a-KRAB fusion improves CRISPRi activity over DNase-dead AsCas12a-KRAB fusions, often rescuing the activities of lentivirally delivered CRISPR RNAs (crRNA) that are inactive when used with the latter. multiAsCas12a-KRAB supports CRISPRi using 6-plex crRNA arrays in high-throughput pooled screens. Using multiAsCas12a-KRAB, we discover enhancer elements and dissect the combinatorial function of cis-regulatory elements in human cells. These results instantiate a group testing framework for efficiently surveying numerous combinations of chromatin perturbations for biological discovery and engineering.

2024-03-06 | GSE260827 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data